SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-11-003830
Filing Date
2011-12-12
Accepted
2011-12-12 17:15:31
Documents
10
Period of Report
2011-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pphm_10q-103111.htm 10-Q 1018252
2 CERTIFICATION pphm_10q-3101.htm EX-31.1 13862
3 CERTIFICATION pphm_10q-3102.htm EX-31.2 13601
4 CERTIFICATION pphm_10q-3200.htm EX-32 12445
  Complete submission text file 0001019687-11-003830.txt   3114514

Data Files

Seq Description Document Type Size
5 XBRL EXHIBIT pphm-20111031.xml EX-101.INS 414106
6 XBRL EXHIBIT pphm-20111031.xsd EX-101.SCH 17364
7 XBRL EXHIBIT pphm-20111031_cal.xml EX-101.CAL 28172
8 XBRL EXHIBIT pphm-20111031_def.xml EX-101.DEF 79636
9 XBRL EXHIBIT pphm-20111031_lab.xml EX-101.LAB 106253
10 XBRL EXHIBIT pphm-20111031_pre.xml EX-101.PRE 91947
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 111256794
SIC: 2834 Pharmaceutical Preparations